1
|
|
2
|
Vandenhove H, Bradshaw C, Beresford NA, Vives I Batlle J, Real A, Garnier-Laplace J. ALLIANCE perspectives on integration of humans and the environment into the system of radiological protection. Ann ICRP 2018; 47:285-297. [PMID: 29671613 DOI: 10.1177/0146645318756831] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Risks posed by the presence of radionuclides in the environment require an efficient, balanced, and adaptable assessment for protecting exposed humans and wildlife, and managing the associated radiological risk. Exposure of humans and wildlife originate from the same sources releasing radionuclides to the environment. Environmental concentrations of radionuclides serve as inputs to estimate the dose to man, fauna, and flora, with transfer processes being, in essence, similar, which calls for a common use of transport models. Dose estimates are compared with the radiological protection criteria for humans and wildlife, such as those developed by the International Commission on Radiological Protection. This indicates a similarity in the approaches for impact assessment in humans and wildlife, although some elements are different (e.g. the protection endpoint for humans is stochastic effects on individuals, whereas for wildlife, it is deterministic effects on species and ecosystems). Human and environmental assessments are consistent and complementary in terms of how they are conducted and in terms of the underlying databases (where appropriate). Not having an integrated approach may cause difficulties for operators and regulators, for communication to stakeholders, and may even hamper decision making. For optimised risk assessment and management, the impact from non-radiation contaminants and stressors should also be considered. Both in terms of the underlying philosophy and the application via appropriate tools, the European Radioecology Alliance (ALLIANCE) upholds that integration of human and ecological impact and risk assessment is recommended from several perspectives (e.g. chemical/radiological risks).
Collapse
Affiliation(s)
- H Vandenhove
- a SCK•CEN, Belgian Nuclear Research Centre, Environment Health and Safety, Boeretang 200, 2400 Mol, Belgium
| | | | - N A Beresford
- c NERC Centre for Ecology and Hydrology, Lancaster Environment Centre, UK
| | - J Vives I Batlle
- a SCK•CEN, Belgian Nuclear Research Centre, Environment Health and Safety, Boeretang 200, 2400 Mol, Belgium
| | - A Real
- d CIEMAT Centre for Research in Energy, Environment and Technology, Spain
| | | |
Collapse
|
3
|
Vaitses Fontanari A, Costa A, Zanella G, Feijo M, Schwarz K, Soll B, Cardoso D, Schneider M, Real A, Lobato M. 450 AIDS related care for transgender people: a systematic review. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
4
|
Garnier-Laplace J, Vandenhove H, Beresford N, Muikku M, Real A. COMET strongly supported the development and implementation of medium-term topical research roadmaps consistent with the ALLIANCE Strategic Research Agenda. J Radiol Prot 2018; 38:164-174. [PMID: 29160233 DOI: 10.1088/1361-6498/aa9c0a] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The ALLIANCE6 Strategic Research Agenda (SRA) initiated by the STAR7 Network of Excellence and integrated in the research strategy implemented by the COMET consortium, defines a long-term vision of the needs for, and implementation of, research in radioecology. This reference document, reflecting views from many stakeholders groups and researchers, serves as an input to those responsible for defining EU research call topics through the ALLIANCE SRA statement delivered each year to the EJP-CONCERT8 (2015-2020). This statement highlights a focused number of priorities for funding. Research in radioecology and related sciences is justified by various drivers, such as policy changes, scientific advances and knowledge gaps, radiological risk perception by the public, and a growing awareness of interconnections between human and ecosystem health. The SRA is being complemented by topical roadmaps that have been initiated by the COMET9 EC-funded project, with the help and endorsement of the ALLIANCE. The strategy underlying roadmap development is driven by the need for improved mechanistic understanding across radioecology. By meeting this need, we can provide fit-for-purpose human and environmental impact/risk assessments in support of the protection of man and the environment in interaction with society and for the three exposure situations defined by the ICRP (i.e., planned, existing and emergency). Within the framework of the EJP-CONCERT the development of a joint roadmap is under discussion among all the European research platforms and will highlight the major research needs for the whole radiation protection field and how these are likely to be addressed by 2030.
Collapse
Affiliation(s)
- J Garnier-Laplace
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, Cadarache-Batiment 159, BP 3, F-13115 Saint-Paul-lez-Durance, France
| | | | | | | | | |
Collapse
|
5
|
Muikku M, Beresford NA, Garnier-Laplace J, Real A, Sirkka L, Thorne M, Vandenhove H, Willrodt C. Sustainability and integration of radioecology-position paper. J Radiol Prot 2018; 38:152-163. [PMID: 29160234 DOI: 10.1088/1361-6498/aa9c0b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This position paper gives an overview of how the COMET project (COordination and iMplementation of a pan-European instrumenT for radioecology, a combined Collaborative Project and Coordination and Support Action under the EC/Euratom 7th Framework Programme) contributed to the integration and sustainability of radioecology in Europe via its support to and interaction with the European Radioecology ALLIANCE. COMET built upon the foundations laid by the FP7 project STAR (Strategic Network for Integrating Radioecology) Network of Excellence in radioecology. In close association with the ALLIANCE, and based on the Strategic Research Agenda (SRA), COMET developed innovative mechanisms for joint programming and implementation of radioecological research. To facilitate and foster future integration under a common federating structure, research activities developed within COMET were targeted at radioecological research needs identified in the SRA. Furthermore, COMET maintained and developed strong mechanisms for knowledge exchange, dissemination and training to enhance and maintain European capacity, competence and skills in radioecology. In the short term the work to promote radioecology will continue under the H2020 project EJP-CONCERT (European Joint Programme for the Integration of Radiation Protection Research). The EJP-CONCERT project (2015-2020) aims to develop a sustainable structure for promoting and administering joint programming and open research calls in the field of radiation protection research for Europe. In the longer term, radioecological research will be facilitated by the ALLIANCE. External funding is, however, required in order to be able to answer emerging research needs.
Collapse
Affiliation(s)
- M Muikku
- Radiation and Nuclear Safety Authority (STUK), PO Box 14, FI-00811 Helsinki, Finland
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Giménez MJ, Real A, García-Molina MD, Sousa C, Barro F. Characterization of celiac disease related oat proteins: bases for the development of high quality oat varieties suitable for celiac patients. Sci Rep 2017; 7:42588. [PMID: 28209962 PMCID: PMC5314403 DOI: 10.1038/srep42588] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2016] [Accepted: 01/11/2017] [Indexed: 12/16/2022] Open
Abstract
Some studies have suggested that the immunogenicity of oats depends on the cultivar. RP-HPLC has been proposed as a useful technique to select varieties of oats with reduced immunogenicity. The aim of this study was to identify both the avenin protein patterns associated with low gluten content and the available variability for the development of new non-toxic oat cultivars. The peaks of alcohol-soluble avenins of a collection of landraces and cultivars of oats have been characterized based on the RP-HPLC elution times. The immunotoxicity of oat varieties for patients with celiac disease (CD) has been tested using a competitive ELISA based on G12 monoclonal antibody. The oat lines show, on average, seven avenin peaks giving profiles with certain similarities. Based on this similarity, most of the accessions have been grouped into avenin patterns. The variability of RP-HPLC profiles of the collection is great, but not sufficient to uniquely identify the different varieties of the set. Overall, the immunogenicity of the collection is less than 20 ppm. However, there is a different distribution of toxicity ranges between the different peak patterns. We conclude that the RP-HPLC technique is useful to establish groups of varieties differing in degree of toxicity for CD patients.
Collapse
Affiliation(s)
| | - Ana Real
- INSERM U1218 "ACTION", Bordeaux University, Bordeaux Cedex, France
| | | | - Carolina Sousa
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | | |
Collapse
|
7
|
Beresford NA, Beaugelin-Seiller K, Burgos J, Cujic M, Fesenko S, Kryshev A, Pachal N, Real A, Su BS, Tagami K, Vives i Batlle J, Vives-Lynch S, Wells C, Wood MD. Radionuclide biological half-life values for terrestrial and aquatic wildlife. J Environ Radioact 2015; 150:270-276. [PMID: 26378959 DOI: 10.1016/j.jenvrad.2015.08.018] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Revised: 08/23/2015] [Accepted: 08/24/2015] [Indexed: 06/05/2023]
Abstract
The equilibrium concentration ratio is typically the parameter used to estimate organism activity concentrations within wildlife dose assessment tools. Whilst this is assumed to be fit for purpose, there are scenarios such as accidental or irregular, fluctuating, releases from licensed facilities when this might not be the case. In such circumstances, the concentration ratio approach may under- or over-estimate radiation exposure depending upon the time since the release. To carrying out assessments for such releases, a dynamic approach is needed. The simplest and most practical option is representing the uptake and turnover processes by first-order kinetics, for which organism- and element-specific biological half-life data are required. In this paper we describe the development of a freely available international database of radionuclide biological half-life values. The database includes 1907 entries for terrestrial, freshwater, riparian and marine organisms. Biological half-life values are reported for 52 elements across a range of wildlife groups (marine = 9, freshwater = 10, terrestrial = 7 and riparian = 3 groups). Potential applications and limitations of the database are discussed.
Collapse
Affiliation(s)
- N A Beresford
- NERC Centre for Ecology & Hydrology, Bailrigg, Lancaster LA1 4AP, UK; School of Environment & Life Sciences, University of Salford, Manchester M4 4WT, UK.
| | - K Beaugelin-Seiller
- Institut de Radioprotection et de Sûreté Nucléaire, PRP-ENV, LM2E, Cadarache, France
| | | | - M Cujic
- Institute for the Application of Nuclear Energy, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia
| | - S Fesenko
- International Atomic Energy Agency, A-2444 Seibersdorf, Austria
| | | | - N Pachal
- Department of Medical Physics and Applied Radiation Sciences, McMaster University, Hamilton, L8S 4K1, Canada
| | - A Real
- Centro de Investigaciones Energéticas Medio Ambientales y Tecnológicas, Av. Complutense 40, Madrid 28040, Spain
| | - B S Su
- Department of Medical Physics and Applied Radiation Sciences, McMaster University, Hamilton, L8S 4K1, Canada
| | - K Tagami
- National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, 263-8555 Chiba, Japan
| | - J Vives i Batlle
- Belgian Nuclear Research Centre, Boeretang 200, 2400 Mol, Belgium
| | | | - C Wells
- NERC Centre for Ecology & Hydrology, Bailrigg, Lancaster LA1 4AP, UK
| | - M D Wood
- School of Environment & Life Sciences, University of Salford, Manchester M4 4WT, UK
| |
Collapse
|
8
|
Real A, Gilbert N, Hauser B, Kennedy N, Shand A, Gillett H, Gillett P, Goddard C, Cebolla Á, Sousa C, Fraser WD, Satsangi J, Ralston SH, Riches PL. Characterisation of osteoprotegerin autoantibodies in coeliac disease. Calcif Tissue Int 2015; 97:125-33. [PMID: 26092508 DOI: 10.1007/s00223-015-0023-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Accepted: 06/09/2015] [Indexed: 01/30/2023]
Abstract
Autoantibodies neutralising the effect of the bone regulatory cytokine osteoprotegerin (OPG) have been described in a patient with severe osteoporosis and coeliac disease. This study aimed to determine the prevalence and epitope specificity of autoantibodies to OPG in patients with coeliac disease, and correlate their presence with bone mineral density. A direct enzyme-linked immunosorbent assay was developed and used to screen patients with coeliac disease for autoantibodies to OPG. Recombinant fragments of OPG were made to evaluate the epitope specificity and affinity of these antibodies. Phenotype information of the patients was obtained by case note review. Raised titres of antibodies to OPG were found in 7/71 (9.8 %) patients with coeliac disease, compared with 1/72 (1.4 %) non-coeliac osteoporosis clinic control patients (p < 0.05). Our results suggest that a polyclonal antibody response to OPG is raised in these patients capable of recognising different epitopes of OPG with varying affinity. The titre of OPG antibodies was associated with lower bone mineral density Z-score of the hip in coeliac patients on univariate (p < 0.05) and multivariate analysis including age, sex height and weight as covariates (p < 0.01). Polyclonal antibodies to OPG are more common in patients with coeliac disease and are independently associated with lower bone mineral density Z-scores of the hip. Further work is required to establish the clinical utility of testing for OPG antibodies.
Collapse
Affiliation(s)
- Ana Real
- Centre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine (IGMM), Edinburgh, EH4 2XU, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
The International Commission on Radiological Protection (ICRP) established Committee 5 in 2005 in response to the need to provide direct demonstration of environmental protection from radiation in accordance with national law and international agreements. The development of the ICRP system for environmental protection was facilitated by research over the previous decades, as well as by ICRP's evaluation of the ethical and philosophical basis for environmental protection as laid out in ICRP Publication 91. The 2007 Recommendations (Publication 103) incorporated environmental protection as one of the integral elements of the radiation protection system. Over a relatively short time, the system has evolved to incorporate a set of 12 Reference Animals and Plants (RAPs), which is a small enough number to develop comprehensive databases for each RAP, but wide ranging enough to provide some insight into radiation impact and protection against such impact, as appropriate, in terrestrial, freshwater, and marine ecosystems. As necessary, the databases can be used to derive supplementary databases for Representative Organisms typical for a particular exposure situation of concern or under study. The system, to date, details biology of the RAPs (Publication 108); outlines transfer factors for estimation of internal concentrations of radionuclides of environmental significance under different situations (Publication 114); provides further information (Publication 108) on dosimetry, biological effects, and derived consideration reference levels (bands of environmental dose rates where potential detrimental effects may deserve attention); and provides information on application of the system in planned, emergency, and existing exposure situations (Publication 124). Currently, a review of experimental determinations of relative biological effectiveness, to guide derivation of specific weighting factors for use in environmental radiation protection if possible and necessary, is being concluded, as is work on improved dosimetry. Further work in this area involves consolidation of databases, recommendations for derivation of specific databases for Representative Organisms on the basis of the RAP data, and recommendations for application of the system to environmental protection in relation to certain human activities of potential environmental concern. Consideration needs to be made for the wider range of ecosystem effects that may be covered in ecological risk assessments, which incorporate the complete suite of stressors that result from human activity, and their effects, to understand the role of radiation effects in this context.
Collapse
Affiliation(s)
- C-M Larsson
- Australian Radiation Protection and Nuclear Safety Agency, PO Box 655, Miranda, NSW 1490, Australia
| | - K A Higley
- Department of Nuclear Engineering and Radiation Health Physics, Oregon State University, USA
| | - A Real
- CIEMAT, Radiation Protection of the Public and the Environment, Spain
| |
Collapse
|
10
|
Real A, Comino I, Moreno MDL, López-Casado MÁ, Lorite P, Torres MI, Cebolla Á, Sousa C. Identification and in vitro reactivity of celiac immunoactive peptides in an apparent gluten-free beer. PLoS One 2014; 9:e100917. [PMID: 24963630 PMCID: PMC4071002 DOI: 10.1371/journal.pone.0100917] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Accepted: 06/01/2014] [Indexed: 12/11/2022] Open
Abstract
Gluten content from barley, rye, wheat and in certain oat varieties, must be avoid in individuals with celiac disease. In most of the Western countries, the level of gluten content in food to be considered as gluten-free products is below 20 parts per million measured by ELISA based on specific anti-gluten peptide antibody. However, in beverages or food suffering complex hydrolytic processes as beers, the relative proportion of reactive peptides for celiac patients and the analytical techniques may differ, because of the diversity of the resulting peptide populations after fermentations. A beer below 20 parts per million of gluten but yet detectable levels of gluten peptides by anti-gliadin 33-mer antibodies (G12 and A1) was analyzed. We identified and characterized the relevant peptides for either antibody recognition or immunoactivity in celiac patients. The beer was fractionated by HPLC. The relative reactivity of the different HPLC fractions to the G12/A1 antibodies correlated to the reactivity of peripheral blood mononuclear cells isolated from 14 celiac individuals. Peptides from representative fractions classified according to the relative reactivity to G12/A1 antibodies were identified by mass spectrometry. The beer peptides containing sequences with similarity to those of previously described G12 and A1 epitopes were synthesized and confirmed significant reactivity for the antibodies. The most reactive peptides for G12/A1 also confirmed the highest immunogenicity by peripheral blood mononuclear cell activation and interferon γ production from celiac patients. We concluded that preparative HPLC combined with anti-gliadin 33-mer G12/A1 antibodies were very sensitive and specific methods to analyze the relevant immunogenic peptides in hydrolyzed gluten.
Collapse
Affiliation(s)
- Ana Real
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Mª de Lourdes Moreno
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | | | - Pedro Lorite
- Departamento de Biología Experimental, Campus Universitario Las Lagunillas, Jaén, Spain
| | - Mª Isabel Torres
- Departamento de Biología Experimental, Campus Universitario Las Lagunillas, Jaén, Spain
| | | | - Carolina Sousa
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
- * E-mail:
| |
Collapse
|
11
|
Gil-Humanes J, Pistón F, Altamirano-Fortoul R, Real A, Comino I, Sousa C, Rosell CM, Barro F. Reduced-gliadin wheat bread: an alternative to the gluten-free diet for consumers suffering gluten-related pathologies. PLoS One 2014; 9:e90898. [PMID: 24621595 PMCID: PMC3951262 DOI: 10.1371/journal.pone.0090898] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2013] [Accepted: 02/06/2014] [Indexed: 12/20/2022] Open
Abstract
Wheat flour cannot be tolerated by those who suffer allergies to gluten. Human pathologies associated with grain proteins have increased worldwide in recent years, and the only effective treatment available is a lifelong gluten-free diet, which is complicated to follow and detrimental to gut health. This manuscript describes the development of wheat bread potentially suitable for celiac patients and other gluten-intolerant individuals. We have made bread using wheat flour with very low content of the specific gluten proteins (near gliadin-free) that are the causal agents for pathologies such as celiac disease. Loaves were compared with normal wheat breads and rice bread. Organoleptic, nutritional, and immunotoxic properties were studied. The reduced-gliadin breads showed baking and sensory properties, and overall acceptance, similar to those of normal flour, but with up to 97% lower gliadin content. Moreover, the low-gliadin flour has improved nutritional properties since its lysine content is significantly higher than that of normal flour. Conservative estimates indicate that celiac patients could safely consume 67 grams of bread per day that is made with low-gliadin flour. However, additional studies, such as feeding trials with gluten-intolerant patients, are still needed in order to determine whether or not the product can be consumed by the general celiac population, as well as the actual tolerated amount that can be safely ingested. The results presented here offer a major opportunity to improve the quality of life for millions of sufferers of gluten intolerance throughout the world.
Collapse
Affiliation(s)
- Javier Gil-Humanes
- Instituto de Agricultura Sostenible, CSIC, Córdoba, Spain
- * E-mail: (JG-H); (FB)
| | | | | | - Ana Real
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Carolina Sousa
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Cristina M. Rosell
- Instituto de Agroquímica y Tecnología de Alimentos, CSIC, Valencia, Spain
| | - Francisco Barro
- Instituto de Agricultura Sostenible, CSIC, Córdoba, Spain
- * E-mail: (JG-H); (FB)
| |
Collapse
|
12
|
Garnier-Laplace J, Geras'kin S, Della-Vedova C, Beaugelin-Seiller K, Hinton TG, Real A, Oudalova A. Are radiosensitivity data derived from natural field conditions consistent with data from controlled exposures? A case study of Chernobyl wildlife chronically exposed to low dose rates. J Environ Radioact 2013; 121:12-21. [PMID: 22336569 DOI: 10.1016/j.jenvrad.2012.01.013] [Citation(s) in RCA: 134] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2011] [Revised: 01/03/2012] [Accepted: 01/16/2012] [Indexed: 05/18/2023]
Abstract
The discrepancy between laboratory or controlled conditions ecotoxicity tests and field data on wildlife chronically exposed to ionising radiation is presented for the first time. We reviewed the available chronic radiotoxicity data acquired in contaminated fields and used a statistical methodology to support the comparison with knowledge on inter-species variation of sensitivity to controlled external γ irradiation. We focus on the Chernobyl Exclusion Zone and effects data on terrestrial wildlife reported in the literature corresponding to chronic dose rate exposure situations (from background ~100 nGy/h up to ~10 mGy/h). When needed, we reconstructed the dose rate to organisms and obtained consistent unbiased data sets necessary to establish the dose rate-effect relationship for a number of different species and endpoints. Then, we compared the range of variation of radiosensitivity of species from the Chernobyl-Exclusion Zone with the statistical distribution established for terrestrial species chronically exposed to purely gamma external irradiation (or chronic Species radioSensitivity Distribution - SSD). We found that the best estimate of the median value (HDR50) of the distribution established for field conditions at Chernobyl (about 100 μGy/h) was eight times lower than the one from controlled experiments (about 850 μGy/h), suggesting that organisms in their natural environmental were more sensitive to radiation. This first comparison highlights the lack of mechanistic understanding and the potential confusion coming from sampling strategies in the field. To confirm the apparent higher sensitive of wildlife in the Chernobyl Exclusion Zone, we call for more a robust strategy in field, with adequate design to deal with confounding factors.
Collapse
Affiliation(s)
- J Garnier-Laplace
- Institute for Radioprotection and Nuclear Safety, IRSN/DEI/SECRE, Cadarache, Building 159, 13115 Saint Paul lez Durance Cedex, France.
| | | | | | | | | | | | | |
Collapse
|
13
|
Comino I, Real A, Moreno MDL, Montes R, Cebolla A, Sousa C. Immunological determination of gliadin 33-mer equivalent peptides in beers as a specific and practical analytical method to assess safety for celiac patients. J Sci Food Agric 2013; 93:933-943. [PMID: 22886585 DOI: 10.1002/jsfa.5830] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2012] [Revised: 06/28/2012] [Accepted: 06/28/2012] [Indexed: 06/01/2023]
Abstract
BACKGROUND Cereals used for beer manufacturing contain gluten, which is immunotoxic for celiac patients. The gluten remaining after processes of malting and brewing is mostly hydrolyzed, which makes practical evaluation of the immunotoxicity of the gluten pools challenging. RESULTS We analyzed the presence of gluten peptides equivalent to the major immunotoxic protease-resistant gliadin 33-mer in 100 Belgium beers, using monoclonal antibodies (G12/A1). Immunochromatographic strips and enzyme-linked immonosorbent assay G12/A1 methods estimated at least 20 ppm gluten equivalents in 90 beers and gluten-free in 10 beers. The G12/A1 reactivity of beer high-performance liquid chromatographic fractions correlated to the presence of T-cell-reactive epitopes identified by peptide sequencing. CONCLUSION The determination of equivalent gliadin 33-mer epitopes in beers has been shown to be practical, specific, and sensitive for the measurement of potential immunotoxicity for celiac patients.
Collapse
Affiliation(s)
- Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Seville, Spain
| | | | | | | | | | | |
Collapse
|
14
|
Palomar G, Paris J, Corominas M, Ramos-Quiroga J, Ferrer R, Catalan R, Real A, Ramirez C, Casas M. 1092 – Cortisol awakening response (CAR) and gender differences in adults with attention deficit hyperactivity disorder (ADHD). Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76200-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
15
|
Hinton TG, Garnier-Laplace J, Vandenhove H, Dowdall M, Adam-Guillermin C, Alonzo F, Barnett C, Beaugelin-Seiller K, Beresford NA, Bradshaw C, Brown J, Eyrolle F, Fevrier L, Gariel JC, Gilbin R, Hertel-Aas T, Horemans N, Howard BJ, Ikäheimonen T, Mora JC, Oughton D, Real A, Salbu B, Simon-Cornu M, Steiner M, Sweeck L, Vives i Batlle J. An invitation to contribute to a strategic research agenda in radioecology. J Environ Radioact 2013; 115:73-82. [PMID: 22885152 DOI: 10.1016/j.jenvrad.2012.07.011] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2012] [Accepted: 07/12/2012] [Indexed: 05/21/2023]
Abstract
With intentions of integrating a portion of their respective research efforts into a trans-national programme that will enhance radioecology, eight European organisations recently formed the European Radioecology ALLIANCE (www.er-alliance.org). The ALLIANCE is an Association open to other organisations throughout the world with similar interests in promoting radioecology. The ALLIANCE members recognised that their shared radioecological research could be enhanced by efficiently pooling resources among its partner organizations and prioritising group efforts along common themes of mutual interest. A major step in this prioritisation process was to develop a Strategic Research Agenda (SRA). An EC-funded Network of Excellence in Radioecology, called STAR (Strategy for Allied Radioecology), was formed, in part, to develop the SRA. This document is the first published draft of the SRA. The SRA outlines a suggested prioritisation of research topics in radioecology, with the goal of improving research efficiency and more rapidly advancing the science. It responds to the question: "What topics, if critically addressed over the next 20 years, would significantly advance radioecology?" The three Scientific Challenges presented within the SRA, with their 15 associated research lines, are a strategic vision of what radioecology can achieve in the future. Meeting these challenges will require a directed effort and collaboration with many organisations the world over. Addressing these challenges is important to the advancement of radioecology and in providing scientific knowledge to decision makers. Although the development of the draft SRA has largely been a European effort, the hope is that it will initiate an open dialogue within the international radioecology community and its stakeholders. This is an abbreviated document with the intention of introducing the SRA and inviting contributions from interested stakeholders. Critique and input for improving the SRA are welcomed via a link on the STAR website (www.star-radioecology.org).
Collapse
Affiliation(s)
- T G Hinton
- French Institute of Radiation Protection and Nuclear Safety (IRSN), Bat 159, BP 3, 13115 Saint-Paul-Lez-Durance, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Real A, Comino I, de Lorenzo L, Merchán F, Gil-Humanes J, Giménez MJ, López-Casado MÁ, Cebolla Á, Sousa C, Barro F, Pistón F. Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. PLoS One 2012; 7:e48365. [PMID: 23284616 PMCID: PMC3524229 DOI: 10.1371/journal.pone.0048365] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2012] [Accepted: 09/25/2012] [Indexed: 12/21/2022] Open
Abstract
A strict gluten-free diet (GFD) is the only currently available therapeutic treatment for patients with celiac disease (CD). Traditionally, treatment with a GFD has excluded wheat, barley and rye, while the presence of oats is a subject of debate. The most-recent research indicates that some cultivars of oats can be a safe part of a GFD. In order to elucidate the toxicity of the prolamins from oat varieties with low, medium, and high CD toxicity, the avenin genes of these varieties were cloned and sequenced, and their expression quantified throughout the grain development. At the protein level, we have accomplished an exhaustive characterization and quantification of avenins by RP-HPLC and an analysis of immunogenicity of peptides present in prolamins of different oat cultivars. Avenin sequences were classified into three different groups, which have homology with S-rich prolamins of Triticeae. Avenin proteins presented a lower proline content than that of wheat gliadin; this may contribute to the low toxicity shown by oat avenins. The expression of avenin genes throughout the development stages has shown a pattern similar to that of prolamins of wheat and barley. RP-HPLC chromatograms showed protein peaks in the alcohol-soluble and reduced-soluble fractions. Therefore, oat grains had both monomeric and polymeric avenins, termed in this paper gliadin- and glutenin-like avenins. We found a direct correlation between the immunogenicity of the different oat varieties and the presence of the specific peptides with a higher/lower potential immunotoxicity. The specific peptides from the oat variety with the highest toxicity have shown a higher potential immunotoxicity. These results suggest that there is wide range of variation of potential immunotoxicity of oat cultivars that could be due to differences in the degree of immunogenicity in their sequences.
Collapse
Affiliation(s)
- Ana Real
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Laura de Lorenzo
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Francisco Merchán
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | | | | | | | - Ma Isabel Torres
- Departamento de Biología Experimental, Campus Universitario Las Lagunillas, Jaén, Spain
| | | | - Carolina Sousa
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Francisco Barro
- Instituto de Agricultura Sostenible (C.S.I.C.), Córdoba, Spain
| | - Fernando Pistón
- Instituto de Agricultura Sostenible (C.S.I.C.), Córdoba, Spain
| |
Collapse
|
17
|
Comino I, Real A, Gil-Humanes J, Pistón F, de Lorenzo L, Moreno MDL, López-Casado MÁ, Lorite P, Cebolla A, Torres MI, Barro F, Sousa C. Significant differences in coeliac immunotoxicity of barley varieties. Mol Nutr Food Res 2012; 56:1697-707. [PMID: 22968973 DOI: 10.1002/mnfr.201200358] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2012] [Revised: 07/19/2012] [Accepted: 07/30/2012] [Indexed: 12/24/2022]
Abstract
SCOPE The only treatment available for coeliac disease (CD) is a strict diet in which the intake of wheat, barley, rye, or oats is avoided. Barley is a major cereal crop, grown mainly for its use in brewing, and it has high nutritional value. The identification of varieties with a reduced toxicity profile may contribute to improve the diet, the quality of life and health of CD patients. METHODS AND RESULTS Searching for harmless barleys, we investigated accessions of malting and wild barley, used for developing new cultivated cereals. The CD toxicity profile of barleys was screened using G12 antibody and cell proliferation and IFN-γ release from peripheral blood mononuclear cells and intestinal biopsies from CD patients. We found a direct correlation between the reactivity with G12 and the immunogenicity of the different barleys. CONCLUSION The malting barleys were less immunogenic, with reduced levels of toxic gluten, and were possibly less harmful to CD patients. Our findings could raise the prospect of breeding barley species with low levels of harmful gluten, and the attractive goal of developing nontoxic barley cultivars, always taking into account the Codex standard for foods for special dietary use for persons intolerant to gluten.
Collapse
Affiliation(s)
- Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Comino I, Real A, Vivas S, Síglez MÁ, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrera A, Cebolla A, Sousa C. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 2012; 95:670-7. [PMID: 22258271 PMCID: PMC3278243 DOI: 10.3945/ajcn.111.026708] [Citation(s) in RCA: 121] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Certain immunotoxic peptides from gluten are resistant to gastrointestinal digestion and can interact with celiac-patient factors to trigger an immunologic response. A gluten-free diet (GFD) is the only effective treatment for celiac disease (CD), and its compliance should be monitored to avoid cumulative damage. However, practical methods to monitor diet compliance and to detect the origin of an outbreak of celiac clinical symptoms are not available. OBJECTIVE We assessed the capacity to determine the gluten ingestion and monitor GFD compliance in celiac patients by the detection of gluten and gliadin 33-mer equivalent peptidic epitopes (33EPs) in human feces. DESIGN Fecal samples were obtained from healthy subjects, celiac patients, and subjects with other intestinal pathologies with different diet conditions. Gluten and 33EPs were analyzed by using immunochromatography and competitive ELISA with a highly sensitive antigliadin 33-mer monoclonal antibody. RESULTS The resistance of a significant part of 33EPs to gastrointestinal digestion was shown in vitro and in vivo. We were able to detect gluten peptides in feces of healthy individuals after consumption of a normal gluten-containing diet, after consumption of a GFD combined with controlled ingestion of a fixed amount of gluten, and after ingestion of <100 mg gluten/d. These methods also allowed us to detect GFD infringement in CD patients. CONCLUSIONS Gluten-derived peptides could be sensitively detected in human feces in positive correlation with the amount of gluten intake. These techniques may serve to show GFD compliance or infringement and be used in clinical research in strategies to eliminate gluten immunotoxic peptides during digestion. This trial was registered at clinicaltrials.gov as NCT01478867.
Collapse
Affiliation(s)
- Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Seville, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Comino I, Real A, de Lorenzo L, Cornell H, López-Casado MÁ, Barro F, Lorite P, Torres MI, Cebolla Á, Sousa C. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut 2011; 60:915-22. [PMID: 21317420 PMCID: PMC3112367 DOI: 10.1136/gut.2010.225268] [Citation(s) in RCA: 108] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND AIMS Coeliac disease (CD) is triggered by an abnormal reaction to gluten. Peptides resulting from partially digested gluten of wheat, barley or rye cause inflammation of the small intestinal mucosa. Previous contradictory studies suggest that oats may trigger the abnormal immunological response in patients with CD. Monoclonal antibodies (moAbs) against the main immunotoxic 33-mer peptide (A1 and G12) react strongly against wheat, barley and rye but have less reactivity against oats. The stated aim of this study is to test whether this observed reactivity could be related to the potential toxicity of oats for patients with CD. METHODS In the present study, different oat varieties, controlled for their purity and by their distinct protein pattern, were used to examine differences in moAb G12 recognition by ELISA and western blot. Immunogenicity of oat varieties was determined by 33-mer concentration, T cell proliferation and interferon γ production. RESULTS Three groups of oat cultivars reacting differently against moAb G12 could be distinguished: a group with considerable affinity, a group showing slight reactivity and a third with no detectable reactivity. The immunogenicity of the three types of oats as well as that of a positive and negative control was determined with isolated peripheral blood mononuclear T cells from patients with CD by measurement of cell proliferation and interferon γ release. A direct correlation of the reactivity with G12 and the immunogenicity of the different prolamins was observed. CONCLUSIONS The results showed that the reactivity of the moAb G12 is proportional to the potential immunotoxicity of the cereal cultivar. These differences may explain the different clinical responses observed in patients suffering from CD and open up a means to identify immunologically safe oat cultivars, which could be used to enrich a gluten-free diet.
Collapse
Affiliation(s)
- Isabel Comino
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, C/Profesor García González, Spain.
| | - Ana Real
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| | - Laura de Lorenzo
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain,Centro Nacional de Biotecnología (CNB-CSIC), Departamento de Genética Molecular de Plantas, Cantoblanco, Madrid, Spain
| | - Hugh Cornell
- School of Applied Sciences, RMIT University, Melbourne, Australia
| | | | - Francisco Barro
- Instituto de Agricultura Sostenible (CSIC), Alameda del Obispo, Córdoba, Spain
| | - Pedro Lorite
- Departamento de Biología Experimental, Campus Universitario Las Lagunillas, Jaén, Spain
| | - Ma Isabel Torres
- Departamento de Biología Experimental, Campus Universitario Las Lagunillas, Jaén, Spain
| | | | - Carolina Sousa
- Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
| |
Collapse
|
20
|
Real A, Güenechea G, Bueren JA, Maganto G. Radioprotection Mediated by the Haemopoietic Stimulation Conferred by AM5: A Protein-associated Polysaccharide. Int J Radiat Biol 2009; 62:65-72. [PMID: 1353777 DOI: 10.1080/09553009214551831] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The haemopoietic and radioprotective effects of a protein-associated polysaccharide named AM5, have been studied following i.v. injection in mice. A dose-related accumulation of the splenic granulocyte-macrophage colony-forming units (CFU-GM) and colony-forming units in the spleen (CFU-S) was observed in mice treated with doses ranging from 0.1 to 0.4 mg/kg of AM5. The accumulation of splenic CFU-S, CFU-GM and BFU-e (erythroid burst-forming units) was always maximal 5 days after treatment with 0.4 mg/kg of AM5, with increases over control values between 300% and 500%. When the number of haemopoietic progenitors was quantified in the bone marrow, only slight increases of CFU-S were obtained, corresponding to the administration of low doses of AM5 (0.1 mg/kg). However, significant increases of circulating CFU-S were observed following administration of higher doses of AM5, suggesting a mobilization of haemopoietic progenitors from this organ. A faster recovery of spleen CFU-GM was observed in mice treated with 0.4 mg/kg of AM5 3 days or 1 day prior to a sublethal irradiation, and at this later time AM5 produced a significant survival enhancement from 10% to 90% in mice irradiated with 7.6 Gy X-rays. This effect was correlated with an increase in the nadir of leucocytes, characteristic of the radiation syndrome.
Collapse
Affiliation(s)
- A Real
- CIEMAT, Instituto de Medio Ambiente, Madrid, Spain
| | | | | | | |
Collapse
|
21
|
Copplestone D, Hingston J, Real A. The development and purpose of the FREDERICA radiation effects database. J Environ Radioact 2008; 99:1456-1463. [PMID: 18343542 DOI: 10.1016/j.jenvrad.2008.01.006] [Citation(s) in RCA: 99] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2007] [Revised: 01/05/2008] [Accepted: 01/14/2008] [Indexed: 05/26/2023]
Abstract
Any system for assessing the impact of a contaminant on the environment requires an analysis of the possible effects on the organisms and ecosystems concerned. To facilitate this, the FREDERICA radiation effects database has been developed to provide an online search of the known effects of ionising radiation on non-human species, taken from papers in the scientific peer reviewed literature. The FREDERICA radiation effects database has been produced by merging the work done on radiation effects under two European funded projects (FASSET and EPIC) and making the database available online. This paper highlights applications for the database, gaps in the available data and explains the use of quality scores to help users of the database determine which papers may benefit their research in terms of techniques and reproducibility.
Collapse
Affiliation(s)
- D Copplestone
- Environment Agency, Chemicals and Radioactive Substances, PO Box 12, Richard Fairclough House, Knutsford Road, Warrington, Cheshire WA4 1HG, United Kingdom.
| | | | | |
Collapse
|
22
|
Abstract
Chelation therapy is an optimal method to reduce the radionuclide-related risks. In the case of uranium incorporation, the treatment of choice is so far i.v infusion of a 1.4% sodium bicarbonate solution, but the efficacy has been proved to be not very high. In this study, we examine the efficacy of some substances: bicarbonate, citrate, diethylenetriamine pentaacetic acid (DTPA), ethidronate (EHBP) and inositol hexaphosphate (phytic acid) to chelate uranium using a test developed by Braun et al. Different concentrations of phytic acid, an abundant component of plant seeds that is widely distributed in animal cells and tissues in substantial levels, were tested and compared to the same concentrations of sodium citrate, bicarbonate, EHBP and DTPA. The results showed a strong affinity of inositol hexaphosphate for uranium, suggesting that it could be an effective chelating agent for uranium in vivo.
Collapse
Affiliation(s)
- D Cebrian
- Radiobiology Laboratory, Radiation Dosimetry Unit, Department of Environment, CIEMAT, Avda Complutense 22, 28040 Madrid, Spain.
| | | | | | | |
Collapse
|
23
|
Real A, Sundell-Bergman S, Knowles JF, Woodhead DS, Zinger I. Effects of ionising radiation exposure on plants, fish and mammals: relevant data for environmental radiation protection. J Radiol Prot 2004; 24:A123-A137. [PMID: 15700702 DOI: 10.1088/0952-4746/24/4a/008] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
In order to develop a framework for the assessment of the environmental impact of radiation, it is necessary to establish the relationship between exposure (dose rate, accumulated dose) and the effects that may be induced in plants and animals. With this purpose in mind, the data available on effects induced by ionising radiation in various wildlife groups have been reviewed as part of the FASSET project. This paper has highlighted that the available information on the effects of low dose rate, continuous irradiation (< 10(3) microGy h(-1)) is reasonable for plants, fish and mammals, but is scarce or non-existent for other wildlife groups. Thus, the effects induced in plants, fish and mammals after chronic exposure to radiation are presented in this paper. The fragmentary nature of the available, relevant information has made it very difficult to characterise the desired dose rate-response relationships in any detail. However, it can be broadly concluded that, although minor effects may be seen at lower dose rates in the most sensitive species and systems, the threshold for statistically significant effects in most studies is about 10(2) microGy h(-1). The responses then increase progressively with increasing dose rate and usually become very clear at dose rates > 10(3) microGy h(-1) sustained for a large fraction of the lifespan.
Collapse
Affiliation(s)
- A Real
- Spanish Research Centre in Energy, Environment and Technology, Avenida Complutense, 22 Madrid 28040, Spain
| | | | | | | | | |
Collapse
|
24
|
Güenechea G, Albella B, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A. AM218, a new polyanionic polysaccharide, induces radioprotection in mice when administered shortly before irradiation. Int J Radiat Biol 1997; 71:101-8. [PMID: 9020969 DOI: 10.1080/095530097144472] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
We have shown that the polyanionic polysaccharide AM218 improves the survival rate of the potentially lethally irradiated mice. This radioprotective effect was highly dependent on the administration schedule, the most efficient protocol being that in which the drug was given shortly before irradiation. The haematopoietic implications in the pharmacological action of AM218 were confirmed by the improved recovery in the three peripheral blood lineages observed in the AM218-treated mice. However, because of a marked increase observed in the number of white blood cells during the period of highest mortality of the control irradiated mice, effects on the neutrophil lineage may account for the effects mediated by AM218 in the irradiated mice. Both in vitro and in vivo treatment with AM218 before irradiation improved the survival rate of CFU-GM progenitors, while no effects were observed on the CFU-S pool. This led us to postulate that the improved survival rate of the committed progenitors, at least the granulocyte-macrophage progenitors, accounts for the radioprotective capacity of AM218.
Collapse
Affiliation(s)
- G Güenechea
- CIEMAT, Instituto de Medioambientc, Madrid, Spain
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures. Stem Cells 1995; 13:175-85. [PMID: 7540471 DOI: 10.1002/stem.5530130209] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We have investigated the mechanism behind the hematopoietic stimulation mediated by AM5, a protein-associated polysaccharide that stimulates in vivo the murine hematopoietic system. A dose-dependent increase in hematopoietic progenitors was observed in long-term bone marrow cultures (LTBMCs) treated in vitro with AM5. The stimulatory effect was more marked in colony-forming units-granulocyte-macrophage (CFU-GM) than in CFU-spleen (CFU-S) progenitors and also more significant in the supernatant than in the adherent layer. This stimulatory effect was reversible, and continuous stimulation with high doses of AM5 was conductive to a progressive exhaustion of the culture. The analysis of the CFU-GM stimulating activity present in the supernatant of AM5-treated cultures revealed a dose-dependent induction of granulocyte-macrophage colony-stimulating activity (GM-CSA), in contrast with control cultures in which no CSA was detected. Northern blots of LTBMC-adherent layers obtained after in vitro treatment with AM5 revealed a significant mRNA expression for interleukin 1 alpha (IL-1 alpha), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage CSF (M-CSF) and granulocyte CSF (G-CSF), in contrast with adherent layers from untreated cultures which only expressed, in detectable levels, M-CSF and stem cell factor (SCF). The SCF expression was down-modulated in AM5-treated cultures. Our results strongly suggest that the hematopoietic stimulation induced by AM5 is mediated by the modulated expression of endogenous hematopoietic growth factors.
Collapse
Affiliation(s)
- G Güenechea
- Unidad de Biología Molecular y Celular, CIEMAT, Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
26
|
Barrett JC, Afshari CA, Annab LA, Burkhart BA, Boyd JA, Owen RD, Futreal PA, Richter KH, Moses HL, Lavker RM, Miller S, Sun TT, Stingl G, Bianchi AB, Navone NM, Conti CJ, Spencer JM, Kahn S, Weinstein IB, Silvers DS, DeLeo VA, Larcher F, Bauluz C, Quintanilla M, Ballestin C, Jorcano JL, Schön M, Haas M, Klein CE, Weber L, Cerri A, Tadini G, Gitto R, Berti E, Cano A, Caulín C, Gómez M, Gandarillas A, Martín M, Montes A, Navarro P, Bastian BC, Van der Piepen U, Römisch J, Pâques E, Hartmann AA, Krieg P, Schnapke R, Feil S, Fürstenberger G, Marks F, Missero C, Cajal SRY, Filvaroff E, Dotto GP, Sherman J, Albert RE, Baxter CS, Bauer G, Höfler P, Götschl M, Viesel E, Jürgensmeier J, Schaefer D, Picht G, Grande T, Real A, Rünqer TM, Möller K, Fuchs P, Bauer C, Epe' B, Gruner S, Diezel W, Macejewski J, Weber H, Eckert R, Volk HD, Sönnichsen N, Bavinck JNB, Vermeer BJ, Van Der Woude FJ, Vandenbroucke JP, Claas FHJ, Griffin EF, Harris H, Tilgen W, Garbe C, Østerlind A, Weiss J, Jung EG, Ruiter DJ, Danen E, Broecker EB, Johnson JP, van Muijen GNP, Halaban R, Krüger-Krasagakes S, Orfanos CE, Newton JA, Bataille V, Cuzick J, Bishop T, Schwaaf A, Azizi E, Bröcker EB, Eberlein B, Froschermaier S, Gollhausen R, Przybilla B, Krasagakis K, Abdel-Naser MB, Lopez-Bran E, Robledo A, Lopez-Bran E, Heine H, Hennig B, Graf G, Nährig J, Niedner R, Schöpf E, Mailhammer R, Reisbach G, Kempkes B, Hültner L, Thalmeier K, Anders F, Zechel C, Schleenbecker U, Leers J, Smith A, Wagner E, Burcin U, Hug H, Fiebich B, Anders A, Gröger H, Schlatterer B, Moll I, Wollina U, Leigh IM, Purkis PE, Markey A, Neill S, Proby C, Glover M, Lane EB, Klein-Szanto AJP, Yaar M, Garmyn M, Gilani A, Gilchrest BA, Bowden GT, Nelson M, Levy J, Tanooka H, Ootsuyama A, Urbach F, van der Leun JC, de Gruijl FR, Kripke ML, Yuspa SH, Glick A, Lee E, Diugosz A, Balmain A, Bums P, Kemp CJ, Stoler AB, Harks F, Boukamp P, Pascheberg U, Breitkreutz D, Hülsen A, Altmeier S, Tomakidi P, Fusenig NE, Lowy DR, Sedman SA, Cohen BD, Schiller JT, Kricker A, Armstrong BK, English D, Heenan PJ, Randell PL, de Gruijl FR, Kelfkens G, van Weelden H, van der Leun JC, Grabbe S, Bruvers S, Granstein RD, Albert R, Miller M, Cody T, Baxter C, Shukla R, Ueda M, Ichihashi M, Yamamura K, Hayashibe K, Funasaka Y, Mishima Y, Fujiwara Y, Ichihashi M, Jimbo T, Mishima Y, Popanda O, Thielmann HW, Jahrens D, Edler L, Ootsuyama A, Tanooka H, Sutter C, Mukhtar H, Strickland PT, Winter H, Schweizer J, Schmidt R, Weber E, Rippmann F, Hecker E, Kopp-Schneider A, Lehmann WD, Stephan M, Troll W, Wei H, Fujiki H, Garte SJ, Frenkel K, Svetek J, Schara M, Pečar S, Hergenhahn M, Kinzel V, Richards J, Plein P, Schiess K, Kaszkin M, Yamamoto S, Wang JC, Kato R, Kuroki T, Hashimoto Y, Osada S, Ohno S, Gilles C, Piette M, Foidart JM, Ranki A, Lassus J, Lehmus A, Niemi KM, Friesel H, Schneider T, Steinbauer B, Sorg B, Winter A, Krauter G, Krauß R, Roeser H, Unger S, Janiaud P, Rueß D, Mechler BM, Stanbridge EJ, Gross MM, Buček M, Klein-Bauernschmitt P, Schlehofer JR, Kosters R, Stark HJ, Okulov VB, Elgjo K, Ushmorov AG, Danilov AO, Zubova SG, Furstenberger G, Faissner A. Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88). J Cancer Res Clin Oncol 1991. [DOI: 10.1007/bf01613300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Segovia JC, Real A, Bueren JA, Almendral JM. In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cells. Blood 1991; 77:980-8. [PMID: 1847313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
The interaction of two strains of the parvovirus minute virus of mice (MVM) with the mouse hematopoietic system has been studied. The immunosuppressive strain MVMi, but not the prototype virus MVMp, inhibited hematopoiesis in vitro, as judged by colony-forming assays of the erythroid burst-forming unit and granulocyte-monocyte colony-forming unit (CFU-GM) progenitors. Interestingly, primitive hematopoietic cells of the stem compartment (CFU-S12d), were equally susceptible to the MVMi cytotoxic infection, unravelling an unprecedented feature of virus-hematopoiesis interactions. The replication of both strains of MVM virus was evaluated in primary myeloid cells of long-term bone marrow cultures. A high viral DNA synthesis and maturation was observed in MVMi-infected myeloid cells, but it was undetectable in MVMp infections; moreover, the expression of the cytotoxic nonstructural NS-1 protein, a more reliable parameter of cell permissiveness to MVM infection, was only detected in MVMi-infected cells. Correspondingly, MVMi was propagated to high titers of infectious virus and it mediated an acute myelosuppression in these cultures. We conclude that MVMi has a wider tropism than was previously suspected and it is proposed that cytotoxic infection of hematopoietic stem cells, besides that of committed progenitors, may provide an additional basis to understand the pathogenesis of certain animal and human bone marrow failures of viral etiology.
Collapse
Affiliation(s)
- J C Segovia
- Unidad de Biología Celular y Molecular, CIEMAT, Madrid, Spain
| | | | | | | |
Collapse
|